Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$960,197,585
+$24,200,159 QoQ
Shares Held
3,780,752
-1.3% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#67
of 4,647 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $4,800,494,597 across 17 Drug Manufacturers - General names. JNJ ranks #2 (20.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,333,307 | $1,599,208,548 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
3,780,752 | $960,197,585 | |
| 3 | ABBV |
AbbVie Inc.
|
2,733,648 | $687,895,182 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,809,518 | $489,523,063 | |
| 5 | AMGN |
Amgen Inc
|
904,954 | $327,701,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,051,819 | $259,226,812 | |
| 7 | PFE |
Pfizer Inc
|
8,609,603 | $207,319,240 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,347,347 | $192,874,134 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $960,197,585 | 3,780,752 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $935,997,426 | 3,829,150 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $822,420,334 | 3,974,005 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $748,742,091 | 4,038,087 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $620,536,029 | 4,062,429 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $689,575,323 | 4,158,076 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $609,505,617 | 4,214,532 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $688,032,374 | 4,245,541 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $638,619,372 | 4,369,317 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $685,445,021 | 4,333,049 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $670,360,052 | 4,276,892 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $668,939,708 | 4,294,958 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $768,911,077 | 4,645,427 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $713,466,860 | 4,603,012 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $806,725,573 | 4,566,802 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $717,101,392 | 4,389,700 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $735,251,212 | 4,142,027 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $698,078,131 | 3,938,826 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $660,056,488 | 3,858,400 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $614,495,387 | 3,804,925 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $656,606,359 | 3,985,713 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $688,140,517 | 4,187,043 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $695,165,401 | 4,417,114 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $655,342,514 | 4,401,817 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $619,434,226 | 4,404,709 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $560,271,414 | 4,272,641 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||